Connect with us

Technology

Sensiva Health names Ben Williamson as Chief Executive Officer

Published

on

Ben Williamson to lead Sensiva Health as Dr. Jim Silliman is stepping down as CEO and will transition to The Board of Directors, effective immediately.

NEW ORLEANS, Sept. 23, 2024 /PRNewswire/ — Sensiva Health today announced that Ben Williamson has been appointed Chief Executive Officer. Williamson will start in his new role immediately as Dr. Jim Silliman transitions to the Board of Directors.

Williamson previously served as Sensiva’s Chief Operating Officer for the last 5-years overseeing operations of Sensiva Health and its laboratory, manufacturing, and technology subsidiaries. During his tenure as COO, Williamson helped grow the business in the midst of a global pandemic, adding new service lines to include diagnostic manufacturing, national logistics, and infection prevention and control. His focus and commitment to the customer experience and how it correlates directly to resident / patient care have set new standards of value in the diagnostic and senior care industries.

Major advocate of the Sensiva Shield service line, Williamson went on to make it clear that his top priority as CEO will be expanding upon Sensiva’s infection prevention and control initiative.

“The early success we’ve seen in our infection prevention and control offering (SHIELD) is testament to the fact that this important service is not only desired but needed nationally. I think we’ve done a great job at creating a scalable offering for any sized organization while providing a plethora of tools and additional service lines our competition simply can’t touch. Education and commitment to resident care are what drives this program forward and I look forward to creating strong partnerships with leading organizations nationally who understand the importance of an enterprise ICP program,” said Williamson.

Silliman is stepping down from his role as CEO and will transition to the Board of Directors with immediate effect. During his tenure, he led the Sensiva Organization through unprecedented growth while building a strong team of collaborative leaders across its 5 corporate operations nationally. In the midst of a global pandemic, Jim emphasized the importance of same day turnaround time for clinical decision-makers. To achieve this, Sensiva strengthened its internal software operation while standing up a 50,000sqft manufacturing facility to control the testing kit supply chain. At a time when other labs struggled to meet 7-day turnaround times, Sensiva consistently met same-day turnaround times to provide clinical leaders with critical information when they needed it most.

Because of the modularity of the Sensiva offering, key customers included hospital systems, public health initiatives, senior living groups, urgent care organizations, and even airlines, movie sets, and the gulf coast oil providers. Jim’s credibility, vast knowledge, and experience in the medical community continue to be a pinnacle in which Sensiva operates on.

“We are thrilled to appoint Ben as Chief Executive at Sensiva Health. Ben is a passionate, customer focused leader who brings a wealth of experience from his previous direct to consumer roles and his time as Sensiva COO. We’ve been through a lot together, and his ability to navigate problems is as impressive as his ability to quarterback a successful organization. Like everyone at Sensiva, he understands that on the other end of every Sensiva product and service is a real human (It’s not a sample, it’s a person), and that carried a lot of weight in our decision-making process,” said Silliman. “Our board believes that Ben will be a natural leader for our people, company, partners, and customers around the country.”

“I am excited for the opportunity to build upon and execute against the important vision Dr. Silliman curated at this incredible organization, arm and arm with our board and growing executive team,” said Williamson. “I have large shoes to fill and plan to double down on our commitment to the customer experience and making all Sensiva products and service lines accessible to both the largest and smallest organizations in the country. I’m driven daily by the dedication to quality and worth ethic of our incredible team. Sensiva truly is a once in a lifetime company and the opportunity to lead it fills me with great pride and gratitude.”

A statement from the Board of Directors:

“On behalf of Sensiva Health, we want to sincerely thank Dr. Silliman for his contributions to our company, and his dedication to our employees and mission as CEO. In the face of extreme adversity and global challenge, Jim importantly remained focused on our customers while improving the lives of the people within our organization and nurturing the culture he created. The foundation Dr. Silliman cultivated is unparalleled in our industry and we are forever grateful for his service as CEO. Looking ahead, we’re eager to uncover the value and expertise Dr. Silliman will bring to the board and could not be more optimistic about the direction of Sensiva Health under Williamson’s leadership.” – Sensiva Health Board of Directors

Sensiva Health is a cutting-edge infection prevention and technology driven healthcare solutions company. From our enterprise infection prevention and control services to industry leading molecular diagnostics and software solutions, Sensiva provides the science, technology, and infrastructure to power critical healthcare initiatives for our most vulnerable population and their providers. Their headquarters and molecular laboratory (Cormeum Lab Services) are located in New Orleans, LA, while Sensiva Health Manufacturing is located in Maple Grove, MN. Sensiva / Cormeum serve all 50 states nationally.

TOLL-FREE (888) 813-0742
EMAIL hello@sensivahealth.com
LinkedIn – Sensiva Health

View original content to download multimedia:https://www.prnewswire.com/news-releases/sensiva-health-names-ben-williamson-as-chief-executive-officer-302253757.html

SOURCE Sensiva Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

American Doctors Return From Medical Mission In Conflict-Affected Syria

Published

on

By

Doctors treated life-threatening conditions, provided specialized care, and delivered critical training to local healthcare providers.

WASHINGTON, Sept. 23, 2024 /PRNewswire/ — Today, 24 Syrian American Medical Society (SAMS) volunteer doctors from the United States returned from a week-long medical mission to northwest Syria, where they provided life-saving medical care and specialized training to local healthcare providers. From September 15-20, 2024, the volunteer physicians conducted a wide range of medical interventions, including complex cardiac procedures, oncological and retina surgeries, pediatrics subspecialty clinics and intensive care consultations, impacting thousands of lives in a region devastated by conflict and last year’s disastrous earthquake.

SAMS Member and group leader of the mission, Dr. Bassel Atassi, an oncologist of Chicago, who completed the week-long mission in northwest Syria, shared, “During our mission, we carried out 277 surgeries and provided 1,367 consultations. Our focus was not only on treating patients but also on training local doctors in pathology, cardiology, and oncology and other essential practices to help them treat and local refugees. The knowledge transfer was crucial in ensuring that the impact of our work extends far beyond our time on the ground”

“This mission represents the unwavering commitment of our volunteers to provide life-saving care in some of the most challenging conditions imaginable,” said SAMS’ President Dr. Mufaddal Hamadeh. “We are proud of the medical impact made and the meaningful training and collaboration with local healthcare providers that will continue to benefit the region long after our departure. The resilience and courage of the people we serve inspire us to continue our vital work in Syria and beyond.”

The mission included a diverse array of medical services and training initiatives aimed at bolstering local healthcare capacity. Highlights included:

Pediatric and Adult Cardiology: Conducting echocardiograms, pacemaker implants, and catheter-based interventions for pediatric patients and performing adult cardiac surgeries, including coronary artery bypass grafting and valve surgeries.Oncology: Performing major surgeries in urological, gastrointestinal, and gynecological oncology while providing oncological consultations and training at SAMS-supported oncology centers.Specialized Consultations and Procedures: Retinal specialists performed vitrectomies and laser procedures, while intensive care specialists led ICU rounds and critical care consultations.Training and Education: The mission delivered hands-on training, crash courses, and a 2-day Pediatric Scientific Conference, focusing on pediatric specialties, benefiting over 200 general pediatricians in northwest Syria.

Syrians and refugees are still recovering from the earthquake that struck the border area in February 2023, but life is improving thanks to the work of SAMS and its countless volunteers and 2,400 staff in the region—nearly half of whom were displaced by the disaster.

For more information, contact:
Blaine Heck / 201-314-9506 / 383715@email4pr.com

About SAMS:
SAMS is a nonprofit, non-political organization that works on the front lines of crisis relief, providing medical and humanitarian assistance to the most vulnerable in Syria, its neighboring countries, and beyond. Last year, SAMS provided lifesaving medical services to 3.6 million people. For more information about SAMS, go to www.sams-usa.net.

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-doctors-return-from-medical-mission-in-conflict-affected-syria-302255719.html

SOURCE Syrian American Medical Society

Continue Reading

Technology

Pyka Secures $40M Series B to Advance Commercialization of Dual-use Autonomous Electric Aircraft

Published

on

By

Funding will accelerate Pyka’s growth and further scale production of its autonomous aircraft for agriculture, defense, and commercial logistics.

ALAMEDA, Calif., Sept. 23, 2024 /PRNewswire/ — Pyka, an electric aviation technology leader that designs and manufactures large-scale autonomous electric aircraft, today announced a $40M Series B raise. The funding round was led by Obvious Ventures, with participation from both new and existing investors, including Piva Capital, Prelude Ventures, Metaplanet Holdings, and Y Combinator.

Pyka is rapidly commercializing autonomous electric aircraft by applying its technology to many of the world’s most critical flight missions, including agricultural crop protection, commercial cargo transportation, and defense logistics.

“This accomplishment is a significant milestone for Pyka,” said Michael Norcia, Co-Founder and Chief Executive Officer at Pyka. “We are designing, developing, and commercializing autonomous electric aircraft at a pace that few companies have been able to achieve. With commercial production well underway, and our aircraft deployed with customers on multiple continents, we are extremely proud of the progress we’ve made as a company thus far. This round of funding brings us one step closer to unlocking autonomous electric flight for society.”

The company currently produces the largest commercially-approved uncrewed aircraft system (UAS) in the United States and maintains active commercial operations across the U.S., Central America, and Brazil. Pyka’s portfolio of customers includes key players in the agriculture, commercial cargo, and defense logistics value chains, such as Dole, Embraer, Sierra Nevada Company, Heinen Brothers Agra Services, and Skyports Drone Services. In early 2024, Pyka delivered three aircraft to the United States Air Force as part of the Agility Prime program.

The new investment will accelerate Pyka’s growth across its dual-use product line. On the commercial side, it will support further investment in Pyka’s domestic manufacturing capabilities, boost production of its Pelican Spray and Pelican Cargo products, and enable expanded operations with both U.S. and international customers. Additionally, the Series B funds will advance the development of new capabilities to support contested logistics operations for the U.S. Department of Defense and allied partners.

“From the beginning, Pyka was focused on getting into the air and getting into business with commercial operations. Their cost-effective mindset and discipline caught our attention,” said Andrew Beebe, Managing Director at Obvious Ventures. “And what got us really excited was the passion of the team and their mission-driven focus on electrifying aviation and decarbonizing one of the worst offenders in the world.”

Pyka’s family of products includes Pelican Spray, a 1,320-lb, fully autonomous, and 100% electric aircraft designed for complex agricultural operations. The aircraft combines best-in-class spray precision and chemical drift reduction technologies to provide safe, clean, and cost-effective crop protection at scale. Pelican Spray is the largest FAA-approved UAS for agricultural operations and the most productive spray UAS on the Market.

Additionally, Pyka produces Pelican Cargo, the world’s first large-scale autonomous electric cargo aircraft capable of heavy-payload, long-range, and off-airport operation. The 100% electric aircraft can transport up to 400 lbs over a range of 200 miles. Pyka has partnered with Sierra Nevada Company to introduce RUMRUNNER, a modified edition of Pelican Cargo, to customers within the U.S. Department of Defense for sustainment in contested logistics operations.

All of Pyka’s products incorporate its proprietary autonomous flight engine and all-electric propulsion system to enable operations in the world’s most complex environments without putting human operators in harm’s way, at unprecedented cost savings to customers.

About Pyka:

Pyka is defining the future of safe, environmentally-friendly, and cost-effective aviation with autonomous electric airplanes for crop protection and cargo delivery. Pyka’s proprietary technology includes autonomous flight control software, flight computers, high energy density batteries, advanced electric propulsion systems, and carbon composite airframes. Learn more at www.flypyka.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pyka-secures-40m-series-b-to-advance-commercialization-of-dual-use-autonomous-electric-aircraft-302255688.html

SOURCE Pyka

Continue Reading

Technology

#PlumeStrong Cycling Challenge 2024 Surpasses Goal by Raising over €610.000 for Street Child to Develop Secondary Schools in Sierra Leone

Published

on

By

PALO ALTO, Calif., Sept. 23, 2024 /CNW/ — Plume completed its fourth annual #PlumeStrong Cycling Challenge (#PSCC24) – a 5-stage 824 km route from Zurich, Switzerland to Venice, Italy that took place from September 2-6, 2024. The #PSCC is a fundraiser to benefit #PlumeStrong, Plume’s social impact initiative with a mission to empower communities worldwide through meaningful initiatives that promote health, education, equality, efficiency, sustainability, technological innovation, and security. #PlumeStrong envisions a world where more individuals, particularly children, have access to education, resources, and opportunities.

During the five-day ride through the iconic mountain passes of Switzerland and Italy, Plume employees and corporate partners were joined by #PlumeStrong Ambassadors Tadej Pogačar, a three-time Tour de France winner, Urška Žigart, a Slovenian professional racing cyclist, currently riding for the Liv AlUla Jayco WorldTeam, Scott Ogden, English Grand Prix motorcycle racer currently competing in the 2024 Moto3 World Championship for MLav Racing, and Marko Baloh, Guinness & WUCA World Record Holder and elite ultra-cyclist and coach. 

Together, #PSCC24 and its supporters raised over €610,000 surpassing the initiative’s original target of €550,000. Recently, #PlumeStrong and its charity partner Street Child announced that the money raised during the #PSCC24 will be used to benefit Street Child’s work in Sierra Leone. The initial goal was to develop 15 rural secondary schools, providing quality education to over 1,500 children annually, teacher training, and the establishment of a community agriculture project to help sustain the school. Due to the excess funds already raised, #PlumeStrong and Street Child are now expanding the project to develop an additional 5 schools bringing the total number to 20.

Fahri Diner

“I am so proud of what the #PlumeStrong team achieved, said Fahri Diner, Founder and CEO of Plume. “We set a goal for this year’s ride and once again exceeded it. The #PlumeStrong Cycling Challenge 2024 (#PSCC24) was indeed a serious ‘challenge’ and not just a social ride – everyone who participated should feel an incredible sense of accomplishment. And more importantly, it was a successful fundraiser to help Street Child to provide additional educational opportunities for children. As is cycling, this was a beautifully orchestrated team effort, and we are so grateful for the commitment of our people, sponsors, partners, support teams and everyone who donated to the #PSCC24. On behalf of all of us at Plume, a big THANK YOU to all.”

Lucinda Dannatt

“We are thrilled by the success of the #PlumeStrong Cycling Challenge 2024, which has exceeded the initial fundraising goal, said Lucinda Dannatt, Director, Policy & Development and Co-Founder at Street Child. “Thanks to the incredible dedication of #PlumeStrong and its supporters, Street Child can now develop an additional 5 secondary schools, bringing the total to 20 schools and ensuring that at least 2,000 children in Sierra Leone will have the opportunity to receive a quality education. A huge thank you to everyone who braved the 800 km of mountain passes or supported us through donations and sponsorships. Your commitment has made this remarkable achievement possible.”

Tadej Pogačar

“Participating in the #PlumeStrong challenge is a point of pride in my life, and I am thrilled to have ridden again with #PlumeStrong,” said Tadej Pogačar. “I recognize the importance of giving back to those in need and this cycling challenge is one of my favorite ways to do so. The money being raised today will impact those in Sierra Leone and beyond, and I’m honored to be part of this great effort.”

Urška Žigart

“It’s a privilege to be a part of this incredible community of individuals all focused on providing opportunities to communities around the world,” said Urška Žigart. “Becoming a #PlumeStrong Ambassador is a milestone for me, made sweeter by the fact that we’re building a bridge to the cycling world. I look forward to participating in these challenges for years to come.”

Watch the #PSCC24 recap video here: https://www.youtube.com/watch?v=N2mPn2VA_nI 

Media queries:
Plume: corporatecomms@plume.com
Street Child: ben.weich@street-child.org 

About Plume
Plume is the creator of the world’s first SaaS experience platform for communications service providers (CSPs) and their subscribers, deployed in more than 60 million locations globally. As the only open and hardware-independent, cloud-controlled solution, Plume enables the rapid delivery of new services for smart homes, small businesses and beyond, at massive scale. On the front end, Plume delivers self-optimizing, adaptive WiFi, cybersecurity, access, parental controls and more. CSPs get robust data- and AI-driven back-end applications for unprecedented visibility, insights, support, operations and marketing. Plume leverages OpenSync®, an open-source framework that comes pre-integrated and supported on the leading silicon, CPE and platform SDKs.

Visit plume.com, plume.com/homepass, plume.com/workpass, plume.com/uprise, and opensync.io.

Follow Plume on LinkedIn and Instagram

© 2024 Plume Design, Inc. All rights reserved. Adaptive, Advanced loT Protection, Concierge, Flow, Harvest, Haystack, HomePass, OpenSync, Plume, Plume Adaptive WiFi, Plume IQ, Powered by Plume, Signal, SuperPod, WorkPass, Work From Here, WorldPass, and the Plume and OpenSync Logos, among others, are trademarks or registered trademarks of Plume Design, Inc. See trademark guidelines.

About Street Child
Street Child is one of the world’s fastest-growing international children’s charities, established in 2008. Street Child works to ensure children are safe, in school and learning even, and especially, in low resource environments and emergencies. The charity works with an expanding network of local organisations and a focus on the power and purpose of inspirational local level organisations sits at the heart of all they do – and has done so since the first partnership in Sierra Leone in 2008.

Today Street Child works in over 25 countries across sub-Saharan Africa, Asia, Europe and the Middle East.  

Learn more

Follow Street Child on LinkedIn and X

View original content to download multimedia:https://www.prnewswire.com/news-releases/plumestrong-cycling-challenge-2024-surpasses-goal-by-raising-over-610-000-for-street-child-to-develop-secondary-schools-in-sierra-leone-302255700.html

SOURCE Plume Design, Inc.

Continue Reading

Trending